butyrylcholinesterase Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

Journal List > Med Cannabis Cannabinoids > v.5(1); 2022 > PMC9149358 Med Cannabis Cannabinoids. 2022; 5(1):…

Freedom WaresApril 20, 2022

Canna~Fangled Abstracts

Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

Med Cannabis Cannabinoids. 2022 Apr 19;5(1):85-94. doi: 10.1159/000524086. eCollection 2022. Tess Puopolo 1 2, Chang Liu 1, Hang Ma 1 2, Navindra P Seeram 1 2…

Freedom WaresApril 19, 2022

Canna~Fangled Abstracts

Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer’s disease

Eur J Med Chem. 2021 Aug 2;223:113735. doi: 10.1016/j.ejmech.2021.113735. Online ahead of print. Xia Jiang 1, Ziwen…

Freedom WaresAugust 5, 2021

Canna~Fangled Abstracts

Aminobenzimidazoles and Structural Isomers as Templates for Dual-Acting Butyrylcholinesterase Inhibitors and hCB2 R Ligands To Combat Neurodegenerative Disorders.

2015 Nov 9. doi: 10.1002/cmdc.201500418. Dolles D1, Nimczick M1, Scheiner M1, Ramler J1, Stadtmüller P1, Sawatzky E1, Drakopoulos A1, Sotriffer C1, Wittmann HJ2, Strasser…

Freedom WaresNovember 9, 2015

butyrylcholinesterase

Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer’s disease

Aminobenzimidazoles and Structural Isomers as Templates for Dual-Acting Butyrylcholinesterase Inhibitors and hCB2 R Ligands To Combat Neurodegenerative Disorders.

Recent Posts

Archives

Categories